BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28547960)

  • 1. Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma.
    Can NY; Ayturk S; Celik M; Sezer YA; Ozyilmaz F; Tastekin E; Sut N; Ustun F; Bulbul BY; Puyan FO; Guldiken S
    Pol J Pathol; 2016; 67(4):332-344. PubMed ID: 28547960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
    Chang WC; Chen JY; Lee CH; Yang AH
    Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
    Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
    Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Escape Mechanism is Impaired in the Microenvironment of Thyroid Lymph Node Metastasis.
    Cunha LL; Nonogaki S; Soares FA; Vassallo J; Ward LS
    Endocr Pathol; 2017 Dec; 28(4):369-372. PubMed ID: 28730569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
    Ito M; Bogdanova T; Zurnadzhy L; Saenko V; Rogounovitch T; Mitsutake N; Kondo H; Maeda S; Nakashima M; Tronko M; Yamashita S
    Endocr J; 2014; 61(12):1221-8. PubMed ID: 25242260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Landscape of Thyroid Cancers: New Insights.
    Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
    Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
    Oliveira G; Polónia A; Cameselle-Teijeiro JM; Leitão D; Sapia S; Sobrinho-Simões M; Eloy C
    Virchows Arch; 2017 May; 470(5):517-525. PubMed ID: 28236059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
    Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
    Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
    Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of M2 TAMs around lymphatic vessels during lymphatic invasion in papillary thyroid carcinoma.
    Kabasawa T; Ohe R; Aung NY; Urano Y; Kitaoka T; Tamazawa N; Utsunomiya A; Yamakawa M
    Sci Rep; 2021 Jan; 11(1):1150. PubMed ID: 33441903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.
    Baser H; Topaloglu O; Tam AA; Alkan A; Kilicarslan A; Ersoy R; Cakir B
    Endocr Pathol; 2016 Sep; 27(3):233-42. PubMed ID: 27256097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.
    Fiumara A; Belfiore A; Russo G; Salomone E; Santonocito GM; Ippolito O; Vigneri R; Gangemi P
    J Clin Endocrinol Metab; 1997 May; 82(5):1615-20. PubMed ID: 9141559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
    Muzza M; Degl'Innocenti D; Colombo C; Perrino M; Ravasi E; Rossi S; Cirello V; Beck-Peccoz P; Borrello MG; Fugazzola L
    Clin Endocrinol (Oxf); 2010 May; 72(5):702-8. PubMed ID: 20447069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
    Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3974-82. PubMed ID: 22948755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.
    Ugolini C; Elisei R; Proietti A; Pelliccioni S; Lupi C; Borrelli N; Viola D; Leocata P; Vitti P; Miccoli P; Toniolo A; Basolo F
    Thyroid; 2014 Feb; 24(2):339-46. PubMed ID: 23915122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
    Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.